Home page > Publications > Papers of Interest > Metronomic in children
Metronomic in children
Drug repurposing in pediatrics and pediatric hematology oncology.
In this review article to published online in Drug Discovery Today, J Blatt and SJ Corey from the University of North Carolina, USA explore the scope of drug repurposing in pediatric hematology oncology and highlight its potential. Drug repurposing in pediatrics and pediatric hematology oncology. lBatt J, Corey SJ. Drug Discov Today. 2012 Jul 23. (...)
Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report
Elena Lygina Daria Morgacheva Avinash Khadela Humzah Postwala Yesha Shah Yulia Dinikina from the Department of Chemotherapy for Hematologic Diseases and Bone Marrow Transplantation for Children, Almazov National Medical Research Centre, St. Petersburg, Russia, Department of Pharmacology, L.M. College of Pharmacy, Navrangpura, Ahmedabad, Gujarat 380009, (...)
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma
As part of a "metronomics" special issue in "Cancer Letters", Shu-Wei Chou and Hsiu-Hao Chang from the Department of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan have just published a (...)
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach
Irene Slavc, Lisa Mayr, Natalia Stepien, Johannes Gojo, Maria Aliotti Lippolis, Amedeo A. Azizi, Monika Chocholous, Alicia Baumgartner,Cora S. Hedrich, Stefan Holm, Astrid Sehested, Pierre Leblond, Karin Dieckmann, Christine Haberler,Thomas Czech, Marcel Kool and Andreas Peyrl from the Medical University of Vienna, Austria, tthe Karolinska (...)
Infantile myofibromatosis: Small bumps pose big problems
Hillary C Lee, Amee A Amin, Kudakwashe R Chikwava, Valeria R Smith, and Caraciolo J Fernandes from the Section of Neonatal-Perinatal Medicine, Department of Pediatrics, the Department of Pathology and Immunology, and the Division of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX, (...)
Intracranial desmoplastic small round cell tumor after childhood acute myeloid leukemia treated with metronomic oral cyclophosphamide
Nazaret Sánchez-Sierra,Marta Perez-Somarriba,Felisa Vázquez-Gómez,Marta González-Vicent,María Nieves Cabrera-Martín,Alvaro Lassaletta from the Department of Pediatric Oncology from the Hospital Universitario Niño Jesús, and the Department of Nuclear Medicine, Hospital Clínico San Carlos, Madrid,Spain have reported in Pediatric Blood and Cancer a case of (...)
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
Arif Manji , Yvan Samson , Rebecca J. Deyell , Donna L. Johnston , Victor A. Lewis , Alexandra P. Zorzi , Jason N. Berman , Kathy Brodeur-Robb , Ellen Morrison , Lynn Kee , Sushil Kumar , Sylvain Baruchel , James A. Whitlock and Daniel A. Morgenstern from the Hospital for Sick Children, University of Toronto, the CHU Sainte-Justine, Montréal, the BC (...)
Medication Errors on Oral Chemotherapy in Children With ALL in a Developing Country
Sapna Oberoi, Amita Trehan and Ram Kumar Marwaha from the Division of Haematology/Oncology in The Hospital for Sick Children,Toronto, Canadaa nd from the Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India have just published in Pediatric Blood and Cancer an article entitled Medication Errors on Oral (...)
Metronomic Chemotherapy and Palliative Radiotherapy as Salvage Treatment of Refractory or Relapsed Pediatric Solid Tumors
In a recent article published in Current Oncology entitled Metronomic Chemotherapy and Palliative Radiotherapy as Salvage Treatment of Refractory or Relapsed Pediatric Solid Tumors A.M. Ali and M.I. El-Sayed from the Department of Radiotherapy and Nuclear Medicine, South Egypt Cancer Institute, Assiut University, Al-methak Street, Assiut, Egypt (...)
Metronomic Chemotherapy as a New Strategy for End-stage Pediatric Oncology Patients in Iran
Mahdi Shahriari and Babak Abdolkarimi from the Pediatric Hematology-Oncology Division, and Department of Pediatrics of the Shiraz University of Medical Sciences in Iran have just published in the Middle East Journal of Cancer a letter entitled: Metronomic Chemotherapy as a New Strategy for End-stage Pediatric Oncology Patients in Iran. In this (...)
